Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
31.01.15 | 11.05% CAGR for Atrial Fibrillation Market to 2019 - A Global Forecast | 150 | PR Newswire | DALLAS, January 31, 2015 /PRNewswire/ --
LifeScienceIndustryResearch.com offers Global Atrial Fibrillation Market 2015-2019 research report of 67 pages that profiles atrial fibrillation industry... ► Artikel lesen | |
31.01.15 | Global Ink Solvents Market to see 5%+ CAGR to 2019 | 23 | PR Newswire | DALLAS, January 31, 2015 /PRNewswire/ --
ReportsnReports.com adds Ink Solvents Market research report with analysis by Chemistry Type, Product Type, Process & Application and Global Forecasts to... ► Artikel lesen | |
31.01.15 | Over 7000 Industry Professionals and Leading Companies in Water to Converge at Water Philippines 2015 | 51 | PR Newswire | MANILA, Philippines, Jan. 31, 2015 /PRNewswire/ -- Widely recognised as the Philippines No. 1 International Water Sanitation, Industrial Wastewater Treatment & Purification Event, 2015 will see the... ► Artikel lesen | |
31.01.15 | Auto Glass Industry 2018-2020 Market Forecasts for Global and Chinese Regions | 35 | PR Newswire | DALLAS, January 31, 2015 /PRNewswire/ --
RnRMarketResearch.com adds latest reports on Auto Glass Industry for Global and China markets with analysis of auto glass market in china and other countries... ► Artikel lesen | |
31.01.15 | PRN_AdminLive - Test Message - Please Delete | 53 | PR Newswire | Test Release
Also by fax to Domino VSI Fax Machines 020 7570 6357, 020 7570 6358, 01865 712
083
and internal Disclose Fax: 020 7454 5182
This is a test. This is a test. This is a test. This is... ► Artikel lesen | |
31.01.15 | Vyvanse (lisdexamfetamine dimesylate) Capsules (CII) Becomes First and Only Treatment Approved by the FDA for Adults with Moderate to Severe Binge Eating Disorder | 51 | PR Newswire | LEXINGTON, Massachusetts, January 30, 2015 /PRNewswire/ --
Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that the U.S. Food and Drug Administration (FDA) approved Vyvanse® (lisdexamfetamine... ► Artikel lesen | |
31.01.15 | AbbVie Announces Top-line Results from Phase 3 Study of All-Oral Treatment for Hepatitis C in Japan | 69 | PR Newswire | - 95 percent SVR12 rate achieved in Japanese patients new to therapy with genotype 1b chronic hepatitis C virus infection without cirrhosis and with a high viral load
- Regulatory filing in Japan... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
PALANTIR TECHNOLOGIES | 2.489 |
EVOTEC | 2.308 |
NEL | 2.228 |
INFINEON | 1.688 |
TUI | 1.555 |
BAYER | 1.358 |
DEUTSCHE BANK | 1.238 |
NVIDIA | 1.193 |
DEUTSCHE LUFTHANSA | 1.128 |
BYD | 1.039 |
VARTA | 1.002 |
RHEINMETALL | 936 |
MERCEDES-BENZ | 892 |
SUPER MICRO COMPUTER | 830 |
AIXTRON SE | 828 |
RENK GROUP | 828 |
TESLA | 828 |
PLUG POWER | 813 |
TEAMVIEWER | 812 |
COMMERZBANK | 773 |
RWE | 768 |
ALLIANZ | 746 |
SIEMENS ENERGY | 733 |
VOLKSWAGEN | 713 |
WALT DISNEY | 703 |